CGTX
Income statement / Annual
Last year (2023), Cognition Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Cognition Therapeutics, Inc.'s net income was -$25.79 M.
See Cognition Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$252,000.00
|
$235,000.00
|
$93,000.00
|
$98,000.00
|
$81,000.00
|
Gross Profit |
-$252,000.00
|
-$235,000.00
|
-$93,000.00
|
-$98,000.00
|
-$81,000.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$37.20 M
|
$30.32 M
|
$18.57 M
|
$12.89 M
|
$14.38 M
|
General & Administrative Expenses |
$13.53 M
|
$13.23 M
|
$10.03 M
|
$4.52 M
|
$3.45 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$13.53 M
|
$13.23 M
|
$10.03 M
|
$4.52 M
|
$3.45 M
|
Other Expenses |
$0.00
|
-$22.22 M
|
-$17.45 M
|
-$10.86 M
|
-$13.16 M
|
Operating Expenses |
$50.72 M
|
$21.33 M
|
$11.15 M
|
$6.55 M
|
$4.67 M
|
Cost And Expenses |
$50.72 M
|
$21.33 M
|
$11.15 M
|
$6.55 M
|
$4.67 M
|
Interest Income |
$27,000.00
|
$22.22 M
|
$17.45 M
|
$10.86 M
|
$13.16 M
|
Interest Expense |
$0.00
|
$28,000.00
|
$893,000.00
|
$1.75 M
|
$1.02 M
|
Depreciation & Amortization |
$252,000.00
|
$235,000.00
|
$93,000.00
|
$98,000.00
|
$81,000.00
|
EBITDA |
-$25.51 M |
-$21.13 M |
-$13.38 M |
-$5.99 M |
-$3.50 M |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$24.94 M
|
$22.15 M
|
$16.88 M
|
$9.57 M
|
$12.99 M
|
Income Before Tax |
-$25.79 M
|
-$21.40 M
|
-$11.72 M
|
-$7.84 M
|
-$4.84 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
-$22.15 M
|
-$1.43 M
|
$2.23 M
|
$2.11 M
|
Net Income |
-$25.79 M
|
$757,000.00
|
-$10.29 M
|
-$10.07 M
|
-$6.95 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
EPS |
-0.86 |
0.0261 |
-0.46 |
-0.46 |
-0.32 |
EPS Diluted |
-0.86 |
0.0261 |
-0.46 |
-0.46 |
-0.32 |
Weighted Average Shares Out |
$29.99 M
|
$28.99 M
|
$22.23 M
|
$21.94 M
|
$21.94 M
|
Weighted Average Shares Out Diluted |
$30.03 M
|
$28.99 M
|
$22.23 M
|
$21.94 M
|
$21.94 M
|
Link |
|
|
|
|
|